Ansgar Wegener
7Patents
2h-index
15Co-inventors
44Inventor score
Filing activity: Oct 10, 2003 → Apr 9, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9617266B2 | Imidazopyrimidine derivatives | Emerging Cross-Sectional Technologies | 5 | Active |
| US9120805B2 | Substituted pyrrolo[1,2-A]pyrazin-1-ones and pyrazolo[1,5-A]pyrazin-4-ones as inhibitors of tankyrase and poly(ADP-ribose)polymerase activity | Human Necessities | 2 | Active |
| US9409914B2 | Triazolo[4,5-d]pyrimidine derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US9855268B2 | Triazolo[4,5-d]pyrimidine derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US9416133B2 | Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors | Human Necessities | 1 | Active |
| US9861635B2 | Macrocycles as kinase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US7348160B2 | Phosphoamidase assay | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.